Industry

PharmaPlus teams up with biopharmaceutical companies to complement and enhance their business development activities throughout the deal-making process from partner identification to deal closure.

Already before 2010 we envisioned the enormous market potential of the Asian pharmaceutical market and secured an Asian key strategic partner for a US Nasdaq-listed pharmaceutical company. Our advisory services continue to include securing strategic partners for western companies wishing to access the China market and vice versa.



Partnering Strategy

Define your partnering strategy

The right partnering strategy for a product or technology is essential for finding the most suitable partners. PharmaPlus is highly experienced in consulting on partnering …

Read more

In-licensing

Find in-licensing opportunities

PharmaPlus works with your company’s scouting team to further increase your accessibility to in-licensing opportunities. Based on your company’s confidential ...

Read more

Out-licensing

Identify best matching partners

Whatever your reasons, we help you find the right partners for your therapeutics and technologies. At PharmaPlus we use a unique combination ...

Read more

Licensing negotiations

Select package or single services

Understanding the complexities on how licensing deal negotiations are undertaken can make the difference between failure and success in your regotiations. PharmaPlus …

Read more

Company licensing deal valuation

Benchmark your deal value

One of the prerequisites of biopharmaceutical licensing negotiations is understanding the possible licensing deal structures available and the financial impact of different deal …

Read more